Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

LF13CMRI

Financiado

In vivo metabolic imaging at low magnetic field

Magnetic resonance imaging (MRI) is an excellent technique for medical diagnosis. Nonetheless, people from rural areas and low-income countries cannot access MRI due to its high associated cost. In recent years, low-field MRI has... ver más

31/08/2026

MPG

190K€

Presupuesto del proyecto: 190K€

Líder del proyecto

MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSE... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-20

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023

I+D

Cerrada hace 1 año

0% 100% 100%

1 Participantes

MPG

189.69K€ | Lider

Proyectos interesantes

HyperULFNMR Hyperpolarized ultra low field ULF magnetic resonance to d... 2M€ Cerrado

EQC2021-006797-P Resonancia Magnética de alta resolución para pequeño animal... 743K€ Cerrado

DIRECT-fMRI Sensing activity induced cell swellings and ensuing neurotra... 2M€ Cerrado

EQC2021-007210-P Equipo de 3T de imagen de resonancia magnética para investig... 840K€ Cerrado

TRYP Transportable Hyperpolarization for Imaging 150K€ Cerrado

PID2021-126059OA-I00 IMAGENES POR RESONANCIA MAGNETICA CON SENSORES ATOMICOS A ES... 109K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 29 meses Fecha Inicio: 2024-03-20
Fecha Fin: 2026-08-31

Presupuesto del proyecto 190K€

Descripción del proyecto Magnetic resonance imaging (MRI) is an excellent technique for medical diagnosis. Nonetheless, people from rural areas and low-income countries cannot access MRI due to its high associated cost. In recent years, low-field MRI has emerged as a potential solution to increase access to MRI, but at the cost of reduced signal sensitivity. This is a limiting factor in terms of resolution, traceable quantities of metabolites, and early detection of tumor tissue. In this context, hyperpolarization (HP) has emerged as the most promising technique to compensate for the sensitivity losses at low magnetic fields. HP can enhance signal intensity by >10,000 times, providing enough signal to image even species at low concentrations, such as metabolites internalized by cancer cells. Here, the first in vivo metabolic imaging methodology with hyperpolarization at low magnetic fields is proposed. The project involves the development of 1H and HP 13C MRI at low field, the study of enzymatic conversion from HP pyruvate to other metabolites, and in vivo metabolic tumor imaging in mice. Para-hydrogen-induced polarization (PHIP) will be used to generate the HP contrast agent. PHIP offers several advantages, including low costs, low instrumentation demands, rapid high-throughput, and scalable production of HP agents in the liquid state. The combination of low-field MRI with PHIP 13C has the potential to provide a method for early cancer detection in a low-cost scanner.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores